Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Grace Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get GRCE alerts

About Amresh Kumar

Grace Therapeutics, Inc. reported in an 8-K filed May 11, 2023 that Amresh Kumar was appointed VP of Program Management, effective May 15, 2023. The proxy statement of Grace Therapeutics, Inc. reports total compensation of $465,650 for Amresh Kumar in fiscal 2026, including a base salary of $310,000. Disclosed compensation is on record for 3 fiscal years. Grace Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Grace Therapeutics, Inc. includes Prashant Kohli (CEO and Board Member), Robert J. DelAversano (CFO and Chief Accounting Officer), A. Brian Davis (Board Member) and 7 others.

“On May 8, 2023, the Company appointed Amresh Kumar, PhD, as its VP of Program Management, effective May 15, 2023.”
Grace Therapeutics, Inc. Form 8-K, filed May 11, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Grace Therapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2026 Grace Therapeutics, Inc. (GRCE) $310,000 $465,650
2025 Grace Therapeutics, Inc. (GRCE) $286,000 $421,563
2024 Grace Therapeutics, Inc. (GRCE) $243,269 $378,019

Recent activity